TARGET-NASH is a study that looks at people with liver problems called Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD). These are conditions where fat builds up in the liver, not due to alcohol. This study helps doctors understand how well current and new treatments are working. It is called a longitudinal observational study, meaning it watches and records data over time without changing how doctors treat patients.
To join the study, you must:
- Be 2 years or older and have NAFLD, as diagnosed by your doctor.
- Be able to give consent or agree to join the study.
Key Points:
- The study does not change your treatment; it just observes your health over time.
- No extra visits to the doctor are needed; information is collected during regular appointments.
- There is no direct payment for participation, but your involvement helps improve understanding of liver diseases.
How understandable was the trial content above?
Hard to understand
Easy to understand